Analyst RatingThe analyst maintains a Buy rating on PRLB shares while increasing the price target to $55, citing steady revenue growth, a solid financial position, and a strong industry position.
Financial PositionOperating cash flow was positive during the quarter at $29.1 million, with funds used for share repurchases and capital expenditures, while increasing its cash position to $138.4 million with no long-term debt.
Revenue GrowthProto Labs reported better-than-expected financial results for their 3Q25, including revenues of $135.4 million, up 8% year-over-year.